PURPOSE: Early identification and treatment of intracranial haematomas in patients sustaining traumatic brain injury is fundamental to successful treatment. This pilot study evaluates the Infrascanner as a handheld medical screening tool for detection, in situ, of brain haematomas in patients with head injury. METHODS: This study included 35 TBI patients aged 17-76 (M = 47.6), admitted to the neurosurgical intensive care unit and observation unit of a University Hospital in a Level 1 trauma centre. The Infrascanner NIRS device uses near infrared light measurements to calculate optical density in brain regions. RESULTS: Results show Infrascanner sensitivity at 89.5% and specificity at 81.2%. PPV was 85% and NPV 86.7%. The device detected 90% of extra-axial, 88.9% of intra-axial and 93.3% of non-surgical haematomas (less than 25 mL). PPV for this classification was 82.3%; 87.5% sensitivity was found when the Infrascanner exam was performed within 12 hours post-trauma, whereas after 12 hours post-trauma, exams had 90.1% sensitivity. CONCLUSIONS: This study demonstrates that the Infrascanner is useful in initial examinations and screenings of patients with head injury as an adjunct to a CT scan or when it is not available and may allow earlier treatment and reduce secondary injury caused by present and delayed haematomas.
PURPOSE: Early identification and treatment of intracranial haematomas in patients sustaining traumatic brain injury is fundamental to successful treatment. This pilot study evaluates the Infrascanner as a handheld medical screening tool for detection, in situ, of brain haematomas in patients with head injury. METHODS: This study included 35 TBIpatients aged 17-76 (M = 47.6), admitted to the neurosurgical intensive care unit and observation unit of a University Hospital in a Level 1 trauma centre. The Infrascanner NIRS device uses near infrared light measurements to calculate optical density in brain regions. RESULTS: Results show Infrascanner sensitivity at 89.5% and specificity at 81.2%. PPV was 85% and NPV 86.7%. The device detected 90% of extra-axial, 88.9% of intra-axial and 93.3% of non-surgical haematomas (less than 25 mL). PPV for this classification was 82.3%; 87.5% sensitivity was found when the Infrascanner exam was performed within 12 hours post-trauma, whereas after 12 hours post-trauma, exams had 90.1% sensitivity. CONCLUSIONS: This study demonstrates that the Infrascanner is useful in initial examinations and screenings of patients with head injury as an adjunct to a CT scan or when it is not available and may allow earlier treatment and reduce secondary injury caused by present and delayed haematomas.
Authors: Silvia Bressan; Marco Daverio; Francesco Martinolli; Daniele Dona'; Federica Mario; Ivan P Steiner; Liviana Da Dalt Journal: Childs Nerv Syst Date: 2014-03 Impact factor: 1.475
Authors: Jason D Riley; Franck Amyot; Tom Pohida; Randall Pursley; Yasaman Ardeshirpour; Jana M Kainerstorfer; Laleh Najafizadeh; Victor Chernomordik; Paul Smith; James Smirniotopoulos; Eric M Wassermann; Amir H Gandjbakhche Journal: Biomed Opt Express Date: 2011-12-20 Impact factor: 3.732
Authors: Wojciech Weigl; Daniel Milej; Dariusz Janusek; Stanisław Wojtkiewicz; Piotr Sawosz; Michał Kacprzak; Anna Gerega; Roman Maniewski; Adam Liebert Journal: J Cereb Blood Flow Metab Date: 2016-09-07 Impact factor: 6.200
Authors: Johan Ljungqvist; Stefan Candefjord; Mikael Persson; Lars Jönsson; Thomas Skoglund; Mikael Elam Journal: J Neurotrauma Date: 2017-03-13 Impact factor: 5.269
Authors: Stefan Candefjord; Johan Winges; Ahzaz Ahmad Malik; Yinan Yu; Thomas Rylander; Tomas McKelvey; Andreas Fhager; Mikael Elam; Mikael Persson Journal: Med Biol Eng Comput Date: 2016-10-13 Impact factor: 2.602